3SBio, Inc. (ADR) (NASDAQ:SSRX)
CAPS Rating:
The Company is engaged in the research, development, manufacture and distribution of pharmaceutical products in the China.
Invest Different
The Company is engaged in the research, development, manufacture and distribution of pharmaceutical products in the China.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
3SBio has drugs on the market, drugs in the pipeline, future projects, and is continuing to seek markets in other countries; all of which, add up to growth.